These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 976684)

  • 1. Clinical investigation on abnormal glucose tolerance in liver cirrhosis.
    Kato K; Kikuchi S; Ito M
    Gastroenterol Jpn; 1976; 11(1):31-7. PubMed ID: 976684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on glucose, amino acid and protein metabolism in patients with liver cirrhosis in relation to plasma levels of human growth hormone (author's transl)].
    Ogura C
    Hokkaido Igaku Zasshi; 1975 Sep; 50(5):489-506. PubMed ID: 815150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose tolerance, free fatty acid, and serum insulin responses in patients with cirrhosis.
    Berkowitz D
    Am J Dig Dis; 1969 Oct; 14(10):691-9. PubMed ID: 4898689
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma insulin response to oral glucose load in hepatic cirrhosis.
    Jain AK; Agarwal BK; Bajpai HS; Gupta JP
    Indian J Med Res; 1983 Sep; 78():388-94. PubMed ID: 6370851
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of acute inhibition of lipolysis on operation of the glucose-fatty acid cycle in hepatic cirrhosis.
    Farrer M; Fulcher GR; Johnson AJ; Record CO; Alberti KG
    Metabolism; 1992 May; 41(5):465-70. PubMed ID: 1588824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Metabolic changes following glucose and tolbutamide loading in liver cirrhosis and their role in the pathogenesis of hepatogenic diabetes mellitus].
    Kopetz K; Wehrmann P
    Klin Wochenschr; 1970 Nov; 48(21):1265-76. PubMed ID: 5519414
    [No Abstract]   [Full Text] [Related]  

  • 7. [Plasma insulin and GH during oral glucose load in liver cirrhosis].
    Greco AV; Ghirlanda G; Altomonte L; Manna R; Rebuzzi AG
    Minerva Med; 1976 Jul; 67(35):2266-72. PubMed ID: 951048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of octanoic acid on serum-levels of free fatty acids, insulin, and glucose in patients with cirrhosis and in healthy volunteers.
    Linscheer WG; Slone D; Chalmers TC
    Lancet; 1967 Mar; 1(7490):593-7. PubMed ID: 4163975
    [No Abstract]   [Full Text] [Related]  

  • 9. Resistance to insulin suppression of plasma free fatty acids in liver cirrhosis.
    Merli M; Leonetti F; Riggio O; Giaccari A; Romiti A; Sbraccia P; Tamburrano G
    J Endocrinol Invest; 1990 Nov; 13(10):787-95. PubMed ID: 2096155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose kinetics and splanchnic uptake following mixed meal ingestion in cirrhotic-diabetic subjects.
    Kiwanuka E; Barazzoni R; Tessari P
    Diabetes Nutr Metab; 2001 Dec; 14(6):315-24. PubMed ID: 11853363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dynamic exploration of carbohydrate metabolism in liver cirrhosis. Determination of free fatty acids and insulin in the blood].
    Perreau P; Joubaud F; Cheguillaume J; Boyer J; Vernin H
    Sem Hop; 1972 Mar; 48(14):957-66. PubMed ID: 4339074
    [No Abstract]   [Full Text] [Related]  

  • 12. The mechanism of the carbohydrate intolerance of cirrhosis.
    Proietto J; Alford FP; Dudley FJ
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1030-6. PubMed ID: 6999005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid metabolism and insulin resistance in cirrhosis.
    Kaye GL; Kruszynska YT; Harry DS; Heslop K; Johnston DG; McIntyre N
    J Hepatol; 1994 Jun; 20(6):782-91. PubMed ID: 7930479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon and glucose tolerance in liver cirrhosis.
    Greco AV; Altomonte L; Ghirlanda G; D'Anna LM; Manna R; Caputo S; Uccioli L
    Acta Endocrinol (Copenh); 1988 Jul; 118(3):337-45. PubMed ID: 2899368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis.
    Petrides AS; Groop LC; Riely CA; DeFronzo RA
    J Clin Invest; 1991 Aug; 88(2):561-70. PubMed ID: 1864966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individual free fatty acids in patients with liver disease.
    Gunnlaugsson O; Berkowitz D
    Am J Dig Dis; 1977 Nov; 22(11):1005-9. PubMed ID: 920697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral glucose in cirrhotics. Effects on plasma aminoacid patterns and the role of insulin and glucagon.
    Marchesini G; Forlani G; Angiolini A; Zoli M; Scolari MP; Bianchi FB; Pisi E
    Diabete Metab; 1979 Jun; 5(2):135-9. PubMed ID: 478083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal glucose tolerance and non-esterified fatty acids (NEFAs) as predictors of non-alcoholic steatohepatitis (NASH): which Ash that ignites the NASH.
    Osman MM; Osman KA; Ahmed MH
    J Clin Gastroenterol; 2007 Jan; 41(1):118-9. PubMed ID: 17198075
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum fatty acid composition predicts development of impaired fasting glycaemia and diabetes in middle-aged men.
    Laaksonen DE; Lakka TA; Lakka HM; Nyyssönen K; Rissanen T; Niskanen LK; Salonen JT
    Diabet Med; 2002 Jun; 19(6):456-64. PubMed ID: 12060056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin levels and glucose intolerance in patients with cirrhosis and non cirrhotic portal fibrosis.
    Vij JC; Gaur SK; Sharma SK; Yadav HS; Kumar N; Anand BS
    J Assoc Physicians India; 1987 Jul; 35(7):479-82. PubMed ID: 3323185
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.